FRASCA, ANGELISA
FRASCA, ANGELISA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Cholesterol as a synaptogenic factor involved in the development of proper synaptic structure in an hiPSC-derived neurons model of Rett syndrome
2025 F. Biella, F.M. Postogna, N. Giancroce, O.M. Roggero, N. Landsberger, A. Frasca
Interpreting the rich dialogue between astrocytes and neurons: An overview in Rett syndrome
2025 F.M. Postogna, O.M. Roggero, F. Biella, A. Frasca
Cholesterol dysregulation in Rett syndrome: implications for synaptic function
2025 F. Postogna, M. Breccia, O. Roggero, F. Biella, C. Cabasino, A. Arcari, N. Giancroce, N. Landsberger, A. Frasca
Role of IL-6 in Rett syndrome: from in vitro findings to in vivo therapeutic target validation
2025 O. Roggero, M. Breccia, F. Postogna, F. Biella, N. Landsberger, E. Boda, A. Frasca
Role of IL-6 in Rett syndrome: from in vitro findings to in vivo therapeutic target validation
2025 O. Roggero, M. Breccia, F. Biella, F. Postogna, E. Boda, A. Frasca
Cholesterol dysregulation in Rett syndrome: implications for synaptic function
2025 F. Postogna, F. Biella, O. Roggero, N. Giancroce, M. Valenza, A. Frasca
Overcoming premature termination codons in neurodevelopmental diseases with Anticodon Engineered tRNAs
2025 S. Pezzini, A. Mustaccia, E. Fara, P. Aboa, G. Faustini, A. Branchini, M. Pinotti, A. Frasca, J. J Porter, J. D Lueck, N. Landsberger
Rett syndrome: a complex disorder with promising therapeutic prospects
2025 J. Sandakly, A. Frasca, N. Landsberger
Role of interleukin 6 in the pathogenesis of Rett syndrome: focus on astrocyte-neuron crosstalk and its therapeutic implication
2024 O. Roggero, M. Breccia, F. Biella, F. Postogna, N. Landsberger, A. Frasca
Reduction in cholesterol supply by Mecp2 null astrocytes contributes to synaptic defects
2024 F. Postogna, M. Breccia, O. Roggero, F. Biella, E. Albizzati, C. Cabasino, A. Arcari, D. Colombo, L. Morelli, E. Chiricozzi, N. Landsberger, A. Frasca
Mecp2 knock-out astrocytes affect synaptogenesis by Interleukin 6 dependent mechanisms
2024 E. Albizzati, M. Breccia, E.M. Florio, C. Cabasino, F.M. Postogna, R. Grassi, E. Boda, C. Battaglia, C. DE PALMA, C. De Quattro, D. Pozzi, N. Landsberger, A. Frasca
Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway
2024 A. Frasca, F. Miramondi, E. Butti, M. Indrigo, M. BALBONTIN ARENAS, F. M Postogna, A. Piffer, F. Bedogni, L. Pizzamiglio, C. Cambria, U. Borello, F. Antonucci, G. Martino, N. Landsberger
Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway
2024 A. Frasca, F. Miramondi, E. Butti, M. Indrigo, M. BALBONTIN ARENAS, F.M. Postogna, A. Piffer, F. Bedogni, L. Pizzamiglio, C. Cambria, U. Borello, F. Antonucci, G. Martino, N. Landsberger
Identification of novel molecules by which Mecp2 knock-out astrocytes exert a synaptotoxic action on neurons
2024 A. Frasca, F. Postogna, M. Breccia, E. Albizzati, D. Pozzi, E. Boda, N. Landsberger
Neural Precursor Cells as a potential therapeutic approach for Rett Syndrome: identification of the involved molecular mechanisms
2024 M. BALBONTIN ARENAS, F.M. Postogna, E. Butti, A. Frasca, N. Landsberger
Engineered tRNAs efficiently suppress CDKL5 premature termination codons
2024 S. Pezzini, A. Mustaccia, P. Aboa, G. Faustini, A. Branchini, M. Pinotti, A. Frasca, J.J. Porter, J.D. Lueck, N. Landsberger
Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice
2024 D. Pozzer, M. Indrigo, M. Breccia, E. Florio, C.A. Franchino, G. De Rocco, F. Maltecca, A. Fadda, M. Rossato, A. Aramini, M. Allegretti, A. Frasca, L. De Filippis, N. Landsberger
GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation
2024 M. Fazzari, G. Lunghi, E.V. Carsana, M. Valsecchi, E. Spiombi, M. Breccia, S.R. Casati, S. Pedretti, N. Mitro, L. Mauri, M.G. Ciampa, S. Sonnino, N. Landsberger, A. Frasca, E. Chiricozzi
Neural Precursor Cells as a potential therapeutic approach for Rett Syndrome: identification of the involved molecular mechanisms
2023 M. BALBONTIN ARENAS, F. Miramondi, E. Butti, G. Martino, A. Frasca, N. Landsberger
Terapia a base di precursori neurali/cellule staminali per la sindrome di Rett/Neural precursor/stem cell-based therapy for Rett syndrome
2023 A. Frasca, F. Miramondi, N. Landsberger